Avricore Health, Inc. (AVCR.V)
0.06
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 13:38
Avricore Health Enterprise Value : 6.374M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 6.374M |
| August 21, 2026 | 6.374M |
| August 20, 2026 | 6.88M |
| August 19, 2026 | 5.361M |
| August 18, 2026 | 5.867M |
| August 17, 2026 | 5.361M |
| August 14, 2026 | 5.361M |
| August 13, 2026 | 5.361M |
| August 12, 2026 | 5.361M |
| August 11, 2026 | 5.361M |
| August 10, 2026 | 5.361M |
| August 07, 2026 | 5.361M |
| August 06, 2026 | 5.361M |
| August 05, 2026 | 5.361M |
| August 04, 2026 | 5.361M |
| July 31, 2026 | 5.361M |
| July 30, 2026 | 5.361M |
| July 29, 2026 | 4.854M |
| July 28, 2026 | 4.854M |
| July 27, 2026 | 4.854M |
| July 24, 2026 | 4.854M |
| July 23, 2026 | 5.361M |
| July 21, 2026 | 5.867M |
| July 20, 2026 | 5.361M |
| July 17, 2026 | 5.361M |
| Date | Value |
|---|---|
| July 16, 2026 | 5.361M |
| July 15, 2026 | 5.867M |
| July 14, 2026 | 5.867M |
| July 13, 2026 | 5.867M |
| July 10, 2026 | 6.88M |
| July 09, 2026 | 6.374M |
| July 08, 2026 | 5.867M |
| July 07, 2026 | 5.867M |
| July 06, 2026 | 5.361M |
| July 03, 2026 | 5.361M |
| July 02, 2026 | 5.361M |
| June 30, 2026 | 6.374M |
| June 29, 2026 | 5.361M |
| June 26, 2026 | 5.361M |
| June 25, 2026 | 5.867M |
| June 24, 2026 | 5.867M |
| June 23, 2026 | 5.361M |
| June 22, 2026 | 5.361M |
| June 19, 2026 | 5.361M |
| June 18, 2026 | 4.854M |
| June 17, 2026 | 4.854M |
| June 16, 2026 | 4.854M |
| June 15, 2026 | 4.854M |
| June 12, 2026 | 5.361M |
| June 11, 2026 | 5.361M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| KDA Group, Inc. | 21.64M |
| HLS Therapeutics, Inc. | 155.36M |
| Spectral Medical, Inc. | 420.22M |
| Resverlogix Corp. | 142.86M |
| Theratechnologies, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2049M |
| Revenue (Quarterly) | 0.0443M |
| Total Expenses (Quarterly) | 0.2492M |
| EPS Diluted (Quarterly) | -0.002 |
| Gross Profit Margin (Quarterly) | -28.89% |
| Profit Margin (Quarterly) | -462.5% |
| Earnings Yield | -32.50% |
| Normalized Earnings Yield | -27.00 |